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Recently in The Lancet, Guenou et al. (2009) demonstrate that human embryonic stem cells (hESCs) can
differentiate into mature keratinocytes able to generate a pluristratified epithelium on immunodeficient
mice. Their findings and the potential clinical use of hESC-derived keratinocytes will be discussed.Postnatal human epidermal keratinocytes
generate cohesive sheets of stratified
epithelium in culture, and these layers
can maintain the characteristics of au-
thentic epidermis (De Luca et al., 2006).
Guenou et al. now report that human
embryonic stem cells (hESCs) can
generate a homogeneous population of
epithelial cells expressing keratins 5/14,
keratin 10, involucrin, filaggrin, integrins
a6/b4, collagen VII, and laminin 5 at levels
similar to those expressed by postnatal
keratinocytes of squamous epithelia
(Guenou et al., 2009). Similarly to post-
natal epidermal cells, such hESC-derived
keratinocytes gave rise to packed and
cohesive colonies and possessed a
remarkable proliferative potential. hESC-
derived keratinocytes were able to form
a functional pluristratified epithelium in
organotypic cultures and after grafting
onto the back of immunodeficient-recip-
ient mice (Guenou et al., 2009).
These data are interesting and intrigu-
ing, particularly in light of related findings
reported previously by other groups.
Similar experiments—some of which
were produced with the same hESC lines
and the same keratinocyte cultivation
methods as in Guenou et al.—have shown
that hESC-derived keratinocytes can
actually behave quite differently from their
postnatal counterpart (Dabelsteen et al.,
2009; Green et al., 2003; Iuchi et al.,
2006). In these studies, and in contrast
with the results obtained by Guenou
et al., hESC-derived keratinocytes gener-
ated fragmented colonies formed by
scattered noncohesive cells and, more
importantly, possessed a much lower
proliferative potential, as compared to
postnatal keratinocytes (Green et al.,
2003; Iuchi et al., 2006). When analyzed
at a molecular level, hESC-derived kerati-8 Cell Stem Cell 6, January 8, 2010 ª2010 Elnocytes displayed an activated p16INK4A/
p14ARF-dependent senescence pathway
(Dabelsteen et al., 2009). Restoration of
their proliferative potential required either
transduction with the E6/E7 genes of
HPV16 (Iuchi et al., 2006) or enforced
expression of the Bmi1 transcription
factor (Dabelsteen et al., 2009). Bmi1
suppresses the p16INK4A/p14ARF path-
way, is naturally expressed by different
types of squamous epithelial stem cells,
and is probably related to their self-
renewal, as observed for hematopoietic
and neural stem cells. It has thus been
proposed that hESCs-derived keratino-
cytes might represent an incomplete
form of, or deviation from, normal squa-
mous epithelial development (Dabelsteen
et al., 2009).
The generation of any specialized cell
type from hESCs has been difficult to
reproduce because of the poorly defined
epigenetic variations between different
hESC lines, the different culture methods
adopted in different laboratories, and the
limited knowledge on the developmental
programs of the specialized cell type
(Murry and Keller, 2008). Guenou et al.
indeed argue that the above discrep-
ancies might be explained by variations
in the hESC differentiation protocols
used in different laboratories. Specifically,
Guenou and colleagues utilized BMP4
and ascorbic acid in their culture medium.
This hypothesis, although unproven, rai-
ses an interesting question: could the
combination of BMP4 and ascorbic acid
generate and sustain a relatively less
differentiated population of hESC-derived
epithelial stem cells or long-lived progen-
itors, compared to the minimally prolifer-
ating hESC-derived keratinocytes that
have been described previously? Per-
forming clonal analyses of such culturessevier Inc.might shed light on the validity of this
model. Human clonogenic keratinocytes
generate three types of clones, holo-
clones, meroclones, and paraclones,
and each are defined according to their
relative proliferative and differentiation
potential. Holoclone-forming cells repre-
sent the stem cells of virtually all human
squamous epithelia, whereas meroclones
and paraclones exhibit properties ex-
pected of more differentiated transient
amplifying progenitors (reviewed in De
Luca et al., 2006).
Additional clues as to whether the
varying differentiation protocols generate
discrete subpopulations of keratinocyte
progenitors could be obtained by consid-
ering the traits of hESC-derived epithelial
populations from a developmental per-
spective. For instance, the sequential
expression of specific isoforms of the
p63 transcription factor correlate with
the development of primitive epithelia
into stratified tissues, and are required
for the maintenance of epithelial stem
cells as well as their terminal differentia-
tion (reviewed in Blanpain and Fuchs,
2007), and thus may differ on hESC-
derived keratinocytes that arise in distinct
culture conditions. The keratinocyte is the
building block of all stratified epithelia,
including the epidermis and corneal,
conjunctival, esophageal, oropharyngeal,
vaginal, and exocervical epithelia. The
markers investigated by Guenou et al.
are common to all squamous epithelia,
and yet each subtype exhibits distinctive
cytokeratin and transcription factor ex-
pression patterns and are formed by
intrinsically specialized keratinocyte sub-
types, even within the same tissue (for
instance, specific expression of keratin 9
in the palmo-plantar epidermis or specific
keratin 3/12 expression in the corneal
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Previewsepithelium). These specialized keratino-
cytes are programmed during develop-
ment to preferentially undergo a site-
specific pattern of basal and suprabasal
differentiation and they maintain their
identity after cultivation and transplanta-
tion onto humans (Mavilio et al., 2006;
Pellegrini et al., 1999). Therefore, recon-
ciliation of the observed discrepancies
with respect to the self-renewal and
proliferative properties of hESC-derived
keratinocytes will require additional stu-
dies, which may also shed light on
their capacity to differentiate into specific
epithelial lineages.
Even once these issues are dealt with
by conducting additional basic research,
a fundamental question remains: is there
a clinical demand for hESC-derived epi-
dermal keratinocytes?
For the last 30 years, patients sus-
taining massive full-thickness burns have
been saved by the application of autolo-
gous cultures of epidermal keratinocytes
(De Luca et al., 2006). Because of the
massive expansion potential of this popu-
lation, the entire body surface of a human
being can be covered by autologous
epidermal stem cells cultured from a tiny
skin biopsy. Being allogeneic, hESC-
derived keratinocytes would presumably
be rejected by the host’s immune system.
Cultured hESCs-derived keratinocytes
could in principle be used to prepare
the wound bed of full-thickness burns
before the transplantation of autologous
epidermal cultures. However, the clinical
performance of autologous-derived grafts
has already been improved by preparing
the wound bed with cadaver skin allo-
grafts (reviewed in De Luca et al., 2006),
which include both epithelial and deeper
dermal layers. These allografts adhere to
the wound bed and greatly reduce infec-
tion, which is otherwise very deleterious
to the survival of the cultured epithelium.
When the autologous culture is ready
for grafting, the epidermal portion of thecadaver allograft is easily removed
mechanically and the autologous culture
is applied to the remaining allodermis,
which is tolerated by the immune system
and remodeled by the patient’s fibro-
blasts. The allodermis gives an optimal
base for engraftment and is crucial to
the clinical success of autologous epi-
dermal cultures (De Luca et al., 2006).
hESC-derived keratinocytes do not
provide such an allodermis. Therefore,
the generation of hESC-derived dermal,
rather than epidermal, structures would
be a breakthrough for the cell therapy of
massive full-thickness burns and other
skin defects, particularly if combined
with autologous epidermal cultures.
As with allogeneic cultures of postnatal
keratinocytes, hESC-derived keratino-
cytes could prove useful as a biological
medication to induce re-epithelialization
of partial-thickness burns or chronic leg
ulcers by stimulating the proliferation
and migration of resident epidermal cells.
However, the intrinsic pluripotency of
hESCs raises crucial safety concerns
related to their ability to form teratomas.
These concerns have not been conclu-
sively solved for any hESC-derived popu-
lation (Kiuru et al., 2009). In contrast, post-
natal donor skin biopsies are a readily
available source of allogeneic cultures
that do not harbor significant safety
concerns and can even be isolated from
living donors (such as foreskins or biop-
sies from plastic surgery interventions).
Up to 1 million grafts can be produced
from a skin biopsy as small as 1 cm2,
which is enough epidermis to cover at
least 10,000 humans or treat hundreds
of thousands of chronic leg ulcers.
Undoubtedly—provided that at least
safety and immune-rejection hurdles are
surmounted (Murry and Keller, 2008)—
the access to a range of differentiated
hESC-derived cell types might provide
new therapies for some of society’s
most devastating diseases, such as heartCell Stem Ceand kidney failure, metabolic and neuro-
degenerative disorders, stroke, many
cases of blindness and deafness, and
spinal cord injury, all of which result from
the absence of one or more critical popu-
lations of cells that the body is unable to
replace (Murry and Keller, 2008). In this
respect, the generation of pluripotent
cells from reprogrammed somatic cells
(autologous iPSCs) could eliminate immu-
nology-related problems. Yet, in contrast,
existing access to postnatal epidermal
stem cells that display such remarkable
proliferative capacity combined with the
availability of established technologies
for their cultivation and clinical application
may suggest that the need for hESC-
derived keratinocytes is less urgent than
for other diseased tissues or organs.
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